MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Appoints Yifat Steuer as the company's new chief operating officer and deputy chief executive officer. Steuer has worked across a range of pharmaceutical companies, including Johnson & Johnson, GSK PLC as well as with start-ups. The company said that Brett Mitchell has moved from executive chair to non-executive chair "to be more in line with corporate structuring of UK listed companies."
MGC also appointed Hannam & Partners as financial and corporate advisers. Says Hannam & Partners is a "highly regarded" UK advisory firm with a track record in UK capital markets, and more recently in the UK and EU cannabis sector.
Current stock price: 0.85 pence, up 6.3% on Tuesday
12-month change: down 72%
By Chris Dorrell; chrisdorrell@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Glaxosmithkline (GSK)